Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy ...

We, survivors, often express our gratitude for life, love, support and research, but what about the patients who do not ...

Tevimbra approved for HER2-negative gastric or gastroesophageal junction adenocarcinoma with PD-L1 expression, in combination ...

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for ...

CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer ...

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on ...

When we got back from the beach, fall was in the air, and we both were back in the reality of doctor appointments, CT scans, ...

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory ...

This Christmas, my wish for all of you is that you read this and feel seen, that someone out there knows how very hard this ...